| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 09/15/2004 | EP1456348A1 Saccharomyces-cerevisiae yeast strain with stable integration and expression of the nucleic acid sequence for a heterologous potassium ion channel |
| 09/15/2004 | EP1456346A2 Novel ecdysone receptor/invertebrate retinoid x receptor-based inducible gene expression system |
| 09/15/2004 | EP1456241A2 Mono-and dual anti-cd4-rantes chemokine/cytokine constructs |
| 09/15/2004 | EP1456239A2 Hybrid proteins with neuregulin heparin-binding domain for targeting to heparan sulfate proteoglycans |
| 09/15/2004 | EP1456236A2 Use of coagulant-active antitrhombin iii for the therapy of angiogenesis-dependent diseases |
| 09/15/2004 | EP1456235A2 Factor viii c2 domain variants |
| 09/15/2004 | EP1456234A2 Epitope regions of a thyrotrophin (tsh) receptor, uses thereof and antibodies thereto |
| 09/15/2004 | EP1456233A1 Haemocyanin from abalone and process of purification thereof |
| 09/15/2004 | EP1456232A2 Genes encoding for membrane synthesis and membrane transport proteins |
| 09/15/2004 | EP1456231A2 Streptococcus antigens |
| 09/15/2004 | EP1456230A2 Flavivirus ns1 subunit vaccine |
| 09/15/2004 | EP1456225A2 Extended native chemical ligation of three or more peptide fragments |
| 09/15/2004 | EP1456223A2 Rapidly maturing fluorescent proteins and methods for using the same |
| 09/15/2004 | EP1456222A2 Non-human primate fc receptors and methods of use |
| 09/15/2004 | EP1456203A1 Ethylene diamine derivatives and their use as orexin-receptor antagonists |
| 09/15/2004 | EP1455841A2 Osteopontin-related compositions and methods |
| 09/15/2004 | EP1455829A1 Treating vascular disease by inhibiting myeloid differentiation factor 88 |
| 09/15/2004 | EP1455823A2 Anti-t cell immunotoxin fusion protein and its therapeutic use |
| 09/15/2004 | EP1455811A2 Isolated cryopyrins, nucleic acid molecules encoding these, and use thereof |
| 09/15/2004 | EP1455809A2 Inhibitors of hepatitis c virus |
| 09/15/2004 | EP1455592A1 Enhanced oil seed protein recovery |
| 09/15/2004 | EP1419277A4 Isolation of membrane bound ligand-specific complexes |
| 09/15/2004 | EP1390381A4 Lipid metabolism regulators in plants |
| 09/15/2004 | EP1294881B1 Control of metabolism with compositions of the human 2-oxoglutarate carrier |
| 09/15/2004 | EP1282425A4 Crystal structures of p-selectin, p- and e-selectin complexes, and uses thereof |
| 09/15/2004 | EP1257576B1 Vasoactive intestinal peptide analogs |
| 09/15/2004 | EP1246638B1 Use of exendins and agonists thereof for the treatment of hypertriglyceridemia |
| 09/15/2004 | EP1192263B1 Pichia methanolica glyceraldehyde-3-phosphate dehydrogenase 1 promoter and terminator |
| 09/15/2004 | EP1032708A4 Nucleic acid ligands of tissue target |
| 09/15/2004 | EP1023319B1 Immuno-reactive peptide ctl epitopes of human cytomegalovirus |
| 09/15/2004 | EP1015482A4 Isolated candida albicans oligopeptide transporter gene |
| 09/15/2004 | EP1015010A4 Prevention of pregnancy miscarriages |
| 09/15/2004 | EP1007095B1 CHIMERIC TOXINS COMPRISING GnRH FOR TARGETED THERAPY |
| 09/15/2004 | EP1001814B1 Controlled release microencapsulated ngf formulation |
| 09/15/2004 | EP0970106B1 uPAR-MIMICKING PEPTIDES |
| 09/15/2004 | EP0942985B1 Broad-spectrum delta-endotoxins |
| 09/15/2004 | EP0938326B1 Synthetic phosphopeptides for treating bone diseases |
| 09/15/2004 | EP0877760B1 Mhc complexes and uses thereof |
| 09/15/2004 | EP0841939B1 Therapeutic agents and autoimmune diseases |
| 09/15/2004 | EP0837881B1 CONJUGATES OF alpha-MSH WITH A FATTY ACID, PREPARATION METHOD THEREFOR, AND USE THEREOF AS A DRUG |
| 09/15/2004 | EP0833919B1 Type f botulinum toxin and use thereof |
| 09/15/2004 | EP0783579B1 Antigenic fragment of the tagA gene and methods for detecting predisposition to peptic ulceration and gastric carcinoma |
| 09/15/2004 | EP0733104B1 Purification of vitamin-k dependent proteins by membrane chromatography |
| 09/15/2004 | EP0725653B1 Vaccine compositions |
| 09/15/2004 | EP0714404B1 Anti-inflammatory peptides |
| 09/15/2004 | EP0707644B1 Use of pharmaceutical compositions for the treatment of neurodegenerative diseases |
| 09/15/2004 | EP0647275B1 Cloning and expression of gonadotropin-releasing hormone receptor |
| 09/15/2004 | EP0624195B1 Novel biologically active polypeptides, preparation thereof and pharmaceutical composition containing said polypeptides |
| 09/15/2004 | CN1529759A Modular transfection system |
| 09/15/2004 | CN1529757A Fusion Protein for secretion of protein of interest in supernatant of bacterial culture |
| 09/15/2004 | CN1529753A Disease-associated protein |
| 09/15/2004 | CN1529714A Modified interfron alpha with reduced immunogenicity |
| 09/15/2004 | CN1529713A Compositions and methods for therapy and diagnosis of ovarian cancer |
| 09/15/2004 | CN1529710A Recombinant protective protein from streptococcus pneumoniae |
| 09/15/2004 | CN1529551A Substantially homogeneous bio-affecting material having predetermined ratio of bio-affecting component to cell targeting component, method for making such material and use |
| 09/15/2004 | CN1528884A Chicken escherichia coli heterotype outer membrane protein cell engineered bacterial strain preparing method |
| 09/15/2004 | CN1528790A Unsaturated fatty acid modified insulin and preparing method thereof |
| 09/15/2004 | CN1528789A Alpha-lipoic acid and its derivative modified insulin and preparing method thereof |
| 09/15/2004 | CN1528788A Cholalic acid derivative medified insulin and preparing method thereof |
| 09/15/2004 | CN1528787A Biological modifying and recombinant human growth hormone compound and preparing method thereof |
| 09/15/2004 | CN1528786A Method for extracting rice protein by alkaline process |
| 09/15/2004 | CN1528785A Bitter gourd blood sugar-reducing extract (KGE) resin preparing method |
| 09/15/2004 | CN1528784A Epidermal staphylococcus regulatory signal polypetide and coding DNA |
| 09/15/2004 | CN1528131A Method for preparing sterile transgenic fish |
| 09/15/2004 | CN1166777C Human Sel-10 polypeptides and polynucleotides that encode them |
| 09/15/2004 | CN1166776C Use of human vascular IBP-like growth factor for preparing reagent for diagnosis of blood vascular disease etc. |
| 09/15/2004 | CN1166772C Process for controlling sialylation of protein produced by mammalian cell culture |
| 09/15/2004 | CN1166690C Hepatitis C inhibitor peptides |
| 09/15/2004 | CN1166689C Method for purifying hemoglobin |
| 09/15/2004 | CN1166688C Method of separating lactotransferrin from whey liquid |
| 09/15/2004 | CN1166687C Medicine combined by moleculae of growth factor and traumatic factor in gall |
| 09/15/2004 | CN1166686C New human protein with the function of inhibiting cancer cell growth and its coding sequence |
| 09/15/2004 | CN1166685C Small molecule ribosome deactivated protein |
| 09/15/2004 | CN1166684C Process of preparing storing fluorescent phycocyanin |
| 09/15/2004 | CN1166683C New BPC peptide salts with organo-protective activity, the process for their preparation and their use in therapy |
| 09/14/2004 | US6792356 Apparatus and method for automated protein design |
| 09/14/2004 | US6791007 Polynucleotide and its use for modulating a defence response in plants |
| 09/14/2004 | US6790951 Expression system in microorganism and its use for expressing heterologous and homologous proteins |
| 09/14/2004 | US6790950 Anti-bacterial vaccine compositions |
| 09/14/2004 | US6790949 Used in the development of a therapeutic agent for neuron or endocrine cell-related diseases; vesicle transport proteins |
| 09/14/2004 | US6790948 For diagnosis, therapy; drug screening of antitumor agents; antiproliferative agents |
| 09/14/2004 | US6790947 Polynucleotides encoding macrophage derived chemokine |
| 09/14/2004 | US6790944 Immunoglobulin a; for diagnosis and therapy; polymerase chain reaction (pcr); northern blot analysis; drugs |
| 09/14/2004 | US6790941 Zinc finger protein derivatives and methods therefor |
| 09/14/2004 | US6790939 Anti-PSCA antibodies |
| 09/14/2004 | US6790937 Recombinant scFV antibodies specific to Eimeria spp. responsible for coccidiosis |
| 09/14/2004 | US6790936 Carboxyamido-triazole (cai); sh domains; for use in cancer therapy; drug screening |
| 09/14/2004 | US6790833 Oligopeptides obtained from the mucd1 domain of the saliva mucin glycoprotein muc7 have a net positive charge |
| 09/14/2004 | US6790831 For use in testing systemic carnitine deficiency |
| 09/14/2004 | US6790828 Glycoprotein mimetics having ability for potentiation of thrombin-mediated activation of protein c and inability to activate thrombin-activatable fibrinolysis inhibitor (tafi), used as anticoagulants |
| 09/14/2004 | US6790826 Human haemopoietic maturation factor |
| 09/14/2004 | US6790823 Compositions and methods for the prevention and treatment of cardiovascular diseases |
| 09/14/2004 | US6790667 Human mitochondrial proteins and polynucleotides encoding the same |
| 09/14/2004 | US6790660 Human kielin-like proteins and polynucleotides encoding the same |
| 09/14/2004 | US6790656 Galanin receptors (galr2); involved in various neurological and neurodegenerative disorders and treatments |
| 09/14/2004 | US6790648 DNA fragmentation factor involved in apoptosis |
| 09/14/2004 | US6790639 Bone morphogenic proteins; for regulating bone homeostasis, adiposity, and calcification of atherosclerotic plaques |
| 09/14/2004 | US6790638 Method for selecting tumours expressing HLA-G, sensitive to anticancer treatment and uses |
| 09/14/2004 | US6790637 Mammalian gene, BCL-W, belongs to the BCL-2 family of apoptosis-controlling genes |
| 09/14/2004 | US6790633 Prevents binding of ras protein in malignant cells |